Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany

KONSTANZ, Germany & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany. This represents a major step by Takeda toward meeting important unmet needs in dengue prevention. According to the World Health Organization (WHO), dengue is the fastest spreading mosquito-borne viral disease. Forty percent of the wor
Source: BusinessWire-Primary

Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany